Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-06-26

FDA Approved: AUROVELA 1.5/30 — Original Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved AUROVELA 1.5/30 (norethindrone acetate and ethinyl estradiol) from Aurobindo Pharma Limited under an Original Application. It is a combined oral co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AUROVELA 1.5/30 (NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL)

Snippet

ORIG AP for AUROVELA 1.5/30 (NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL)